Nagendran Sukumar
President and Head of R&D
Nagendran Sukumar has filed 6 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jul 10, 2026.
On the most recent filing, Nagendran Sukumar is listed as President and Head of R&D at Taysha Gene Therapies, Inc. Inside the rolling window, Nagendran Sukumar reported no open-market purchases and 7 open-market sales totaling $5.3M in TSHA. The largest disclosed transaction in the window is a sale of 200,000 TSHA shares on Jul 10, 2026, worth $1.2M.
Companies traded
Other insiders at TSHA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.3M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| TSHA | President and Head of R&D | Sale | 200,000 | $1.2M | Jul 10 | SEC ↗ | |
| TSHA | President and Head of R&D | Sale | 200,000 | $892K | Apr 13 | SEC ↗ | |
| TSHA | President and Head of R&D | Sale | 89,132 | $423K | Jan 27 | SEC ↗ | |
| TSHA | President and Head of R&D | Sale | 26,918 | $124K | Jan 27 | SEC ↗ | |
| TSHA | President and Head of R&D | Sale | 200,000 | $942K | Jan 14 | SEC ↗ | |
| TSHA | President and Head of R&D | Sale | 110,125 | $523K | Dec 1 | SEC ↗ | |
| TSHA | President and Head of R&D | Sale | 260,047 | $1.2M | Dec 1 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 10, 2025 | TSHA | Sale | $646K |
Frequently asked questions
How many SEC Form 4 filings has Nagendran Sukumar made?
Nagendran Sukumar has filed 6 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.
Which companies does Nagendran Sukumar trade?
Nagendran Sukumar has filed SEC Form 4 disclosures for 1 company, including TSHA.
When was Nagendran Sukumar's most recent SEC Form 4 filing?
Nagendran Sukumar's most recent SEC Form 4 filing on Tracefour is dated Jul 10, 2026.
What is Nagendran Sukumar's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Nagendran Sukumar is listed as President and Head of R&D.
What is Nagendran Sukumar's total buy and sell value in the current window?
Inside the rolling retention window, Nagendran Sukumar bought $0 and sold $5.3M based on SEC Form 4 filings.
What was Nagendran Sukumar's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 200,000 TSHA shares on 2026-07-10, worth $1.2M, per SEC Form 4 filings.